Immunostaining for Ki-67 demonstrated a reduction in staining intensity in orthotopic xenograft tumors with ITLN1 overexpression, confirming that ITLN1 inhibits HCC growth (Fig. 3D). Here, ITLN1 is linked to hepatocellular carcinoma.